Acquired cystic kidney disease (ACKD) is characterized by the development of multiple cysts in the patients of chronic renal failure without a history of hereditary cystic renal disease. ACKD is for the most part clinically asymptomatic, but clinical concern about ACKD has increased because of its relation to renal cancer.
INT RO DUCT IO N Acquired cystic kidney disease (ACKD) is characterized by the development of multiple cysts in the patients of chronic renal failure without a history of hereditary cystic renal disease. ACKD is for the most part clinically asymptomatic, but clinical concern about ACKD has increased because of its relation to renal cancer.
In 1977, Dunnil et al. 1 ) first described ACKD in patients on maintenance hemodialysis (HD). Since then there have been a number of reports on the association of ACKD with HD 2 -8 ) . However, there have been only a few reports about the prevalence of ACKD in patients receiving continuous ambulatory peritoneal dialysis (CAPD) 9 -1 1 ) . We compared the prevalence of ACKD between HD and CAPD patients and evaluated the possible factors which might affect the development of ACKD.
C o m p a r is o n o f Ac q u ir e d Cy s t ic Kid n e y D is e a s e b e t w e e n He m o d ia ly s is a n d C o n t in u o u s A m b u la t o ry P e r it o n e a l D ia ly s is R ES ULT S
PATIENTS 's CHARACTERIS TICS
The mean age of our patients was 50 years (range, 15-79) and 47 patients were men. The mean dialysis duration of these patients was 49.3 months (range, 12-186 months). Primary renal disease cons isted of diabetes mellitus (n=32), chronic glomerulonephritis (n=30), hypertension(n=12), unknown(n=10) and others(n=14). The clinical and laboratory findings of patients are shown in Table 1 . There were no significant differences in age, sex, underlying renal disease, dialys is duration and the levels of hemoglobin and hematocrit between the two groups . The levels of BUN and serum creatinine in CAPD patients were significantly lower than in HD patients.
PREVALENCE AND NUMBER OF CYSTS
The prevalence of ACKD was about 31%(30/98) and there was no s ignificant difference between HD and CAPD patients (27% vs. 34%, P>0.05). The size of cysts was not different between the two groups , but the number of cysts in CAPD patients was higher than in HD patients (5.5 2.7 vs. 3.5 0.7, P<0.05)( Table 2 ). The duration of dialysis in ACKD patients was not s ignificantly different between the two groups (HD; 79. 4 36.4 vs. CAPD; 70.6 40.1 months).
CLINICAL AND LABORATORY PARAMETERS BETWEEN PATIENTS WITH AND WITHOUT

ACKD.
The presence or absence of ACKD is tabulated, based on the clinical and laboratory parameters ( Table  3) . The mean age, sex, underlying renal disease, erythropoietin use, and laboratory findings were not different between the two groups. However, duration of dialysis was significantly longer in the patients with ACKD than in those without ACKD. When the patients were divided into 2 groups according to the duration of dialysis , the prevalence of ACKD was 14% in the group of 3 years dialysis and 45% in the group of more than 3 years dialysis (P<0.05)( Table 4) .
D IS C US S IO N
Our study demonstrates that prevalence of ACKD is not different between CAPD and HD patients. In general, CAPD is commonly supposed to be at less risk of developing ACKD than HD 12 , 1 3 ) . But recent studies have found the incidence is nearly equal between the two modes of dialysis 1 0 , 1 1 , 1 4 ) . Our study clearly shows that dialysis mode dose not affect the occurrence of ACKD. ACKD is more commonly observed in patients on dialysis for longer periods 1 4 -16 ) . Matson et al 14 ) have s hown that, after 1 to 3 years of dialysis, the prevalence of ACKD is 10% to 20%, rising thereafter to reach 40% to 60% at 3 to 5 years of dialysis , and more than 90% after 5 to 10 years of dialys is. In our result, prevalence of ACKD was 14%(6 of 44 patients) in patients on dialysis for less than 3 years and 45%(24 of 55 patients) for more than 3 years. In addition, the mean dialysis duration of the patients with ACKD was s ignificantly longer than that of the patients without ACKD (74.4 vs.
Ta ble 1. Co mpa ris o n of c linica l a nd la bo rato ry c ha ra cte ris tics be twe e n HD a nd CAPD patie nts .
HD(n=49)
CAPD ( There has been a controversy over the relationship between erythrocytosis and ACKD. Some authors reported that there is a significant positive correlation between occurrence of ACKD and improvement of anemia, and this relation is associated with an increase of erythropoietin levels 3 , 1 9 ) or cyst size 4 ) . On the other hand, others reported that there was no correlation between level of hemoglobin and presence of ACKD 5 ,6 ,2 0 ) . In our study, there were no significant differences in the level of hemoglobin, hematocrit and erythropoietin use between patients with and without ACKD. Even when we excluded patients who had received erythropoietin treatment, we could not find any relation between hemoglobin levels and ACKD. (Data were not shown) Although the level of BUN was higher in HD patients than in CAPD patients, there was no difference between patients with ACKD and those without ACKD. This finding suggests that ACKD is not related to the degree of uremia.
COMPARIS ON OF A CQUIRED CYS TIC KIDNE Y DISEASE BE TWEEN HEMODIALYSIS AND CONTINUOUS AMBULA TOR Y PERITONEAL DIALYSIS
In the majority of patients with ACKD, clinical features are asymptomatic and incidentally detected by ultrasound, CT scanning or at autopsy 1 6 , 1 8 ) . Apart from bleeding, the most significant complication of ACKD is the development of renal tumors. It is clear that the incidence of renal cancer is significantly increased in ACKD patients 7 , 1 6 , 1 8 ) . Truong et al. 2 1) , through a comprehensive review of the literature, represented that there is up to a 50-fold increased risk of renal cell carcinoma in ACKD compared to the general population. We already have experienced 2 cases of renal cell carcinoma associated with ACKD in our dialyzed patients. Both patients were men who had been treated exclus ively with CAPD for more than 2 years . The presenting symptom of one patient was frank pain with perirenal hematoma, and the other was weight loss 2 2 ) .
Therefore, it seems to be very important to detect ACKD before it develops into renal cell cancer, considering t he asymptomatic clinical features of ACKD. It is generally agreed that there is a need for regular screening of symptomatic ACKD patients for early detection of renal cell carcinoma. However, whether screening is needed for asymptomatic patients remains controversial because of the lack of data about the effect of screening on t he outcome of patients 2 1 ,2 3 ) .
Nevertheless, many investigators recommend that patients s hould undergo annual screening after the third year of dialysis because the incidence of ACKD increases significantly after 3 years of dialysis 5 , 16 , 1 7 ) .
Recently, Sarasin et al. 2 4 ) reported that screening for ACKD offers dialyzed patients as much as a 1.6 year gain in life expectancy. They used strategies of performing either computed tomography or ultrasound every three years in all dialysis patients, and annually in patients who were found to have cysts .
Sonography or CT scanning is useful as initial screening tools. In general, CT scanning is preferable to sonography. The reasons are that the small kidneys of end stage renal disease and cysts less than 1 cm are often difficult to image by sonography, and CT scanning is probably more sensitive than sonography for detecting solid tumor 9 , 1 8 ,2 5 ) . However, our preference is sonography as a screening procedure because of its easy availability and economic reason. In summary, an ultrasound study in our patients with ES RD revealed a similar prevalence of ACKD, irrespective of t he mode of dialysis, i.e., HD or CAPD. We also found that the duration of dialysis is significantly related to its development as shown by other studies. On the basis of our experience and previous literature, we recommend periodic screening of ACKD and renal tumor by ultrasonography in patients on dialysis.
